Proof of Concept Evaluation of Drug-Device Interaction With Aclidinium Bromide Via Genuair and Tiotropium Bromide Via HandiHaler in COPD Using Impulse Oscillometry
Phase of Trial: Phase IV
Latest Information Update: 23 Mar 2017
Price : $35 *
At a glance
- Drugs Aclidinium bromide (Primary) ; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Proof of concept; Therapeutic Use
- Acronyms MAN04
- 13 Nov 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 04 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 may 2015 as reported by ClinicalTrials.gov record.
- 04 Mar 2015 Planned primary completion date changed from 1 Dec 2014 to 1 may 2015 as reported by ClinicalTrials.gov record.